Pin Oak Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Pin Oak Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,054	Closed	-$9K	–	427
2020 Q3	$9K	Hold	1,054	–	–	0.01%	313
2020 Q2	$13K	Hold	1,054	–	–	0.01%	267
2020 Q1	$9K	Hold	1,054	–	–	0.01%	306
2019 Q4	$10K	Hold	1,054	–	–	0.01%	324
2019 Q3	$7K	Sell	1,054 -167	-14%	-$1.28K	0.01%	358
2019 Q2	$11K	Hold	1,221	–	–	0.01%	347
2019 Q1	$19K	Hold	1,221	–	–	0.02%	261
2018 Q4	$19K	Hold	1,221	–	–	0.02%	251
2018 Q3	$26K	Hold	1,221	–	–	0.02%	239
2018 Q2	$30K	Buy	1,221 +167	+16%	+$3.41K	0.02%	231
2018 Q1	$18K	Hold	1,054	–	–	0.01%	281
2017 Q4	$20K	Buy	+1,054	New	+$15.9K	0.02%	278

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Pin Oak Investment Advisors's TEVA Position: Q4 2020 in Review

Pin Oak Investment Advisors sold out of Teva Pharmaceuticals (TEVA) in Q4 2020, closing a stake of 1,054 shares — an estimated $9K sold.

Pin Oak Investment Advisors first reported a position in TEVA in Q4 2017 and held it in 12 quarters. The position peaked at $30K in Q2 2018. 449 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

Pin Oak Investment Advisors reported no remaining Teva Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Pin Oak Investment Advisors sold 1,054 Teva Pharmaceuticals shares in Q4 2020, an estimated $9K.
Pin Oak Investment Advisors first reported a position in Teva Pharmaceuticals in Q4 2017 and held it in 12 quarters.
Pin Oak Investment Advisors's Teva Pharmaceuticals position peaked at $30K in Q2 2018.
449 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2020.

Based on Pin Oak Investment Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.